Information on the outcomes in patients with ABC and germline BRCA1/2 mutations are very limited, and only a few trials included these patient populations in their subanalyses [47,63] or performed retrospective analyses [22,23,24] (Figure 1 and Table 1). This evidence concerns the gene BRCA1 and aneurysmal bone cyst.